Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 31, Issue 6, 2002, Pages 377-379

  Pantoja, Lucía ^a,b   González López, Marcos Antonio ^a   Bouso, Marta ^a   Alija, Antonio ^a   Ortiz Saracho, Juan ^a  

^a HOSPITAL EL BIERZO   (Spain)

^b NONE   (Spain)

Author keywords

Papulosquamous lesions; Rheumatoid arthritis; Subacute cutaneous lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOUBLE STRANDED DNA; GOLD SALT; HLA DR3 ANTIGEN; HYDROCHLOROTHIAZIDE; NAPROXEN; OLSALAZINE; PENICILLAMINE; PHOTOSENSITIZING AGENT; PIROXICAM;

ADULT; ANTIBODY DETECTION; ARTICLE; BACK; CASE REPORT; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; ERYTHEMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOGENETICS; PAPULOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODY FORMATION; ARTHRITIS, RHEUMATOID; AUTOANTIGENS; COMORBIDITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED; RIBONUCLEOPROTEINS;

EID: 0036437926     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097402320817130     Document Type: Article

References (14)

1. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: A cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979;115:1409-15.
2. Parodi A, Caproni M, Cardinali C, Bernacchi E, Fuligni A, De Panfilis G, et al. Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus. Dermatology 2000;200:6-10.
3. Callen JP, Klein J. Subacute cutaneous lupus erythematosus: Clinical, serologic, immunogenetic and therpaeutic considerations in 72 patients. Arthritis Rheum 1988;31:1007-13.
4. Lee LA, Robwerts CM, Frank MB, MCCubbin VR, Reichlin M. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus. Arch Dermatol 1994;130:1262-8.
5. Sontheimer RD Systemic Lupus Erythematosus and the skin. In: Lahita RG ed. Systemic Lupus Erythematosus. Third Edition. San Diego. Academic Press, 1999:631-56.
6. Bielsa I, Herrero C, Ercilla CG, Collado A, Font J, Ingelmo M, et al. Immunogenetic findings in cutaneous lupus erythematosus. J Am Acad Dermatol 1991;25:251-7.
7. Sontheimer RD, Maddison PJ, Reichlin M, Jordon RE, Slastny P, Gilliam JN. Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus errythematosus. Ann intern Med 1982;97:664-71.
8. Johansson-Stephansson E. Koskimies S, Pastanenen J, Kariniemi AL. Subacute cutaneous lupus erythematosus: Genetic markers and clinical and immunologic findings in patients. Arch Dermatol 1989;125:791-6.
9. Bell DA, Madison PJ. Serologic subsets in systemic lupus erythematosus: An examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 1980;23:1268-73.
10. Cohen S, Stastny P, Sontheimer RD. Concurrence of cuacute cutaneous lupus erythematosuis and rheumatoid arthritis. Arthritis Rheum 1986;29:421-5.
11. Boire G, Menard H-A. Clinical significance of anti-RO(SSA) antibody in rheumatoid arthritis. J Rheumatol 1988;15:391-4.
12. Sontheimer RD. Subacute cutaneous lupus erythematosus: A decade's perspective. Med Clin North Am 1989;73:1073-92.
13. Gunnarsson I, Pettersson E, Lindblad S, Ringertz B. Olsalazine-induced lupus syndrome. Scan J Rheumatol 1997;26:65-6.
14. Bleuminks GS, Ter Bog EJ, Ramselaar CG, Stricker BHCh. Etanercept-induced subacute cutaneous lupus erythematosus. Rheumatology 2001;40:1317-9.